Executive summary

This updated October 2026 case study revisits a founder’s $30 million C‑corporation exit and shows how a validated Section 1202 QSBS exclusion, a five‑year installment note and coordinated pre‑closing deductions reduced immediate federal/state tax and converted a one‑time tax shock into predictable multi‑year recognition. The combined plan saved roughly $2.9 million of immediate tax liability and—given today’s higher interest rates—delivered a present‑value deferral benefit of approximately $0.6M–$1.0M depending on discount assumptions.

Background

The client was the majority shareholder and founder of a privately held C corporation that sold to a strategic buyer in late 2025 for a $30 million purchase price: $6 million cash at closing and a $24 million five‑year seller note. The founder had continuous ownership since original issuance (well over seven years) and the business had satisfied the small‑business gross‑asset and active‑business tests necessary for Section 1202 QSBS treatment. The owner filed married filing jointly; the spouse’s W‑2 income provided an adjustable withholding lever.

Key facts

  • Sale price: $30,000,000
  • QSBS‑eligible gain: $10,000,000 (claimed under Section 1202 up to the $10M cap)
  • Remaining taxable gain: $20,000,000
  • Payment terms: $6,000,000 cash at closing; $24,000,000 five‑year promissory note (AFR + spread)
  • Filing status: married filing jointly

The challenge

The founder faced two interlocking problems.

  1. Large one‑time tax exposure. Recognizing the full gain in a single year would generate a headline federal capital gains + NIIT bill large enough to push effective rates higher, strain liquidity and create state tax exposure.
  2. Year‑end timing and estimated tax risk. The sale closed late in the calendar year, exposing the seller to underpayment penalties unless estimated taxes and withholding were managed precisely.

Objectives

  • Maximize lawful exclusion under Section 1202 where available.
  • Defer and spread recognition of the non‑QSBS portion to smooth bracketing and reduce immediate marginal tax costs.
  • Use pre‑closing deductions (retirement contributions, bunching charitable gifts) to lower taxable income in the sale year.
  • Coordinate estimated tax safe‑harbors and withholding to avoid penalties and preserve liquidity.

Strategy executed

The advisor team—tax counsel, outside valuation specialists, actuaries and the founder’s CPA—implemented a four‑part plan. The mechanics are the same as earlier versions of this case, but we updated assumptions and implementation details to reflect the economic and enforcement environment in 2026.

1. QSBS carve‑out with rigorous contemporaneous substantiation

The team documented QSBS eligibility for a $10M portion of the gain. Because Section 1202 permits a 100% exclusion for qualifying small‑business stock held more than five years (limited to the greater of $10M or 10x basis), the advisors focused on establishing: (a) original‑issue stock status; (b) gross assets under the statute at time of issuance; and (c) satisfaction of the active‑business test for the required period.

Documentation assembled included board minutes, capitalization tables, audited financials, investor subscription documents, and a written legal opinion. Given heightened audit attention on large QSBS claims (see Implementation below), the team also developed a clearly indexed electronic evidence packet for quick production to revenue agents if necessary.

2. Five‑year installment sale for the non‑QSBS tranche

The buyer agreed that $6M would be paid at closing and $24M via a five‑year amortizing note. The seller elected installment sale treatment under Section 453 for the $20M taxable portion, so gain from principal is recognized as payments are received. Interest income is reported separately as ordinary income.

Why this remains attractive in 2026 but with caveats:

  • Smoothing. Installment timing flattened taxable recognition across five years, reducing year‑one marginal rate interactions and potential phase‑outs.
  • Time value of money. Previously low interest rates increased the PV advantage of deferral; in 2026, AFRs and market rates are higher than the pre‑2022 era, so the PV benefit is smaller but still material. In this case the present‑value tax deferral benefit is estimated at $0.6M–$1.0M (range reflects discount rates of ~4%–6%).
  • Structuring tradeoffs. Higher market rates mean buyer‑requested interest and security (e.g., collateral, subordination) can be more onerous. Sellers must balance tax deferral with commercial note terms.

3. Pre‑closing deductible contributions and charitable planning

To reduce taxable income in the sale year, the founder accelerated deductible items and used tax‑efficient charitable vehicles:

  • Maximized salary deferrals and employer profit‑sharing contributions within plan limits.
  • Established and funded a one‑year cash‑balance plan that produced a large single‑year deductible employer contribution—appropriate given the founder’s age and compensation history and executed after actuarial review.
  • Bunched charitable gifts into a donor‑advised fund (DAF) to maximize itemized deductions for the sale year while allowing multi‑year grant timing from the DAF.

These actions reduced the sale‑year taxable income base and helped ensure the cash‑at‑closing portion did not push other income into substantially higher tax brackets.

4. Estimated taxes, withholding and penalty avoidance

To avoid underpayment penalties, the advisors used two reliable levers:

  • Safe‑harbor payments: the client made estimated tax payments equal to 110% of the prior tax year liability (the high‑income safe‑harbor threshold) and additional quarter‑end payments tied to projected installment receipts.
  • Withholding adjustments: the spouse’s employer increased W‑2 withholding during the remainder of the year—the practical benefit being that withholding is treated as paid evenly for penalty purposes.

Combined, these steps reduced the risk of penalty while preserving flexibility to manage tax obligations as installment payments arrived in future years.

Implementation

Timeline and execution steps (high level)

  1. T‑60 to closing: Confirm QSBS facts; obtain board minutes and audited statements; coordinate valuation and legal opinion workstreams.
  2. T‑30 to closing: Negotiate note economics (term, amortization, security, interest tied to AFR + spread); finalize cash‑balance plan design and actuarial valuation; set up DAF and fund it.
  3. Closing day: Deliver documentation packet; elect installment sale treatment in writing; collect cash at closing and record note.
  4. Post‑closing (30–90 days): File estimated‑tax payments; adjust spouse withholding; monitor note payments and tax recognition schedule; retain documentation for audit defense.

Resources used: transactional counsel, tax controversy counsel (for opinion letter), valuation firm, qualified actuary, CPA and a DAF sponsor.

Results — numbers and metrics

Illustrative numeric outcome (approximate, rounded):

  • Without planning (baseline): full $30M gain taxed at 20% federal capital gains + 3.8% NIIT = 23.8% federal plus assumed 5% state tax → combined ≈ 28.8%; total tax ≈ $8.64M.
  • With Section 1202 exclusion on $10M: immediate taxable gain falls to $20M. At the same combined rate (~28.8%), immediate tax ≈ $5.76M — a reduction of ≈ $2.88M attributable to QSBS exclusion.
  • Installment deferral: recognition of much of the $20M is spread over five years. The present‑value tax deferral benefit, given 2026 discount rates, is estimated at $0.6M–$1.0M depending on exact AFR and discount assumptions.
  • Cash‑flow effect: $6M closing cash satisfied liquidity needs and the DAF funding; tax payments were managed via withholding and safe‑harbor payments to avoid penalties.

Net effect: materially lower immediate tax, smoothed cash‑flow, and reduced penalty risk. The exact present‑value benefit of deferral narrowed compared with earlier low‑rate environments, but remained meaningful for planning.

Lessons learned

  • Document early and comprehensively. Contemporaneous evidence (cap tables, subscription agreements, financial statements and board minutes) is the single most important determinant of withstandable QSBS claims.
  • Revisit installment economics in a higher‑rate market. Elevated AFRs reduce PV gains from deferral and can increase buyer pushback on interest/security; model both tax and commercial outcomes before committing.
  • Coordinate actuarial and tax timing. Cash‑balance or defined‑benefit pumps give a large single‑year deduction but require actuarial setup and ongoing compliance—account for set‑up lead times and trustee selection.
  • Manage estimated taxes proactively. Use safe‑harbors and withholding together; because withholding counts as paid ratably, it is often the simplest lever to eliminate penalty exposure late in the year.
  • Expect scrutiny. Large QSBS exclusions attract IRS and state interest. A legal opinion plus an organized evidence packet reduces exam friction and response time.

Takeaways

  • Section 1202 can convert a mult‑million tax liability into immediate savings but requires robust contemporaneous documentation.
  • Installment sales still smooth recognition, but in 2026 the time‑value benefit is smaller than in prior low‑rate years—model economics before locking terms.
  • Pre‑closing deductible funding (retirement plans, DAFs) is highly effective at lowering recognized taxable income in a sale year.
  • Combine safe‑harbor estimated payments with withholding adjustments to avoid underpayment penalties, especially for late‑year closings.
  • Cross‑disciplinary coordination—tax counsel, valuation, actuary and CPA—is essential to execute and defend the plan.

Implementation notes on risk and audit posture (2026 context)

Tax agencies continue to prioritize large, high‑dollar transactions for review. While Section 1202 remains a powerful tool, expect revenue agents to probe original issue, active‑business facts and use of proceeds. Maintain an indexed digital evidence packet and consider obtaining a written legal opinion from counsel experienced in QSBS litigation to materially reduce exam risk.

FAQ

Is QSBS (Section 1202) still worth pursuing in 2026?

Yes—where the facts support it, Section 1202 remains a high‑value exclusion (100% exclusion for qualifying stock up to the statutory cap). The key is rigorous documentation and independent review; the exclusion’s value is unchanged in principle, though its audit profile is higher for large claims.

Does a higher AFR in 2026 make installment sales unattractive?

Not necessarily. Higher AFRs reduce the present‑value tax advantage of deferral because the discount rate is larger, but installment treatment still smooths tax recognition and can improve cash‑flow management and bracketing across years. Evaluate note pricing, security requirements and the buyer’s commercial needs before proceeding.

How aggressive can I be with cash‑balance or defined‑benefit plans before a sale?

You can make significant deductible contributions, but these plans require actuarial design, trustee selection and compliance. They should be implemented with sufficient lead time and with clear documentation tying the plan to reasonable compensation history and business facts to withstand scrutiny.

What documentation should I assemble for a QSBS claim?

At minimum: subscription agreements and issuance documents, capitalization tables, audited or reviewed financial statements, board minutes evidencing corporate actions, records showing the active‑business test, and a valuation memo showing basis allocation. An indexed digital packet and a written counsel opinion materially improve audit readiness.

Should I change residence/state before a large sale to save state tax?

State moves can produce savings, but they carry timing tests, domicile issues and potential clawbacks. Any residency change should be planned months (often a year) in advance with documentation of intent, physical presence, and severance of prior ties. Consult state tax counsel before relying on a move for tax savings.

Readers: this is an updated, illustrative case. Exact outcomes will depend on facts, note terms, state rules and current interest rates. For any transaction, confirm specifics with transaction counsel, valuation experts and your CPA before relying on QSBS, installment treatment, or major plan funding.